DOI:
10.1055/s-00000169
American Journal of Perinatology Reports
LinksClose Window
References
Chapman PB, Hauschild A, Robert C , et al; BRIM-3 Study Group.
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
N Engl J Med 2011;
364: 2507-2516
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.